Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma

To analyze whether neoadjuvant chemotherapy (NAC) changes the expression rates of invasive ductal carcinoma (IDC) markers: estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), Ki67, and P53. This was a retrospective study of 112 IDC patients who underw...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Peng, Jian-Heng, Zhang, Xiang, Song, Jun-Long, Ran, Liang, Luo, Rong, Li, Hong-Yuan, Wang, Yong-Hong
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer Health 2019
Soggetti:
5750
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6336639/
https://ncbi.nlm.nih.gov/pubmed/30633152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000013554
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi